Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 394

1.

Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.

Suzuki L, Ten Kate FJC, Gotink AW, Stoop H, Doukas M, Nieboer D, Spaander MCW, van Lanschot JJB, van Wijnhoven BPL, Koch AD, Bruno MJ, Looijenga LHJ, Biermann K.

PLoS One. 2019 Jul 8;14(7):e0219494. doi: 10.1371/journal.pone.0219494. eCollection 2019.

2.

Do pathologists agree with each other on the histological assessment of pT1b oesophageal adenocarcinoma?

Gotink AW, Ten Kate FJ, Doukas M, Wijnhoven BP, Bruno MJ, Looijenga LH, Koch AD, Biermann K.

United European Gastroenterol J. 2019 Mar;7(2):261-269. doi: 10.1177/2050640618817693. Epub 2018 Dec 6.

3.

Penile intraepithelial neoplasia: Nomenclature, incidence and progression to malignancy in the Netherlands.

Hoekstra RJ, Trip EJ, Ten Kate FJ, Horenblas S, Lock MT.

Int J Urol. 2019 Mar;26(3):353-357. doi: 10.1111/iju.13871. Epub 2018 Dec 3.

PMID:
30508877
4.

The Amsterdam ReBus progressor cohort: identification of 165 Barrett's surveillance patients who progressed to early neoplasia and 723 nonprogressor patients.

Duits LC, Klaver E, Bureo Gonzalez A, Boerwinkel DF, Ten Kate FJW, Offerhaus GJA, Meijer SL, Visser M, Seldenrijk CA, Krishnadath KK, Schoon EJ, Weusten BLAM, Mallant-Hent RC, Pouw RE, Bergman JJGHM.

Dis Esophagus. 2018 Jun 4. doi: 10.1093/dote/doy037. [Epub ahead of print]

PMID:
29873685
5.

Improved Progression Prediction in Barrett's Esophagus With Low-grade Dysplasia Using Specific Histologic Criteria.

Ten Kate FJC, Nieboer D, Ten Kate FJW, Doukas M, Bruno MJ, Spaander MCW, Looijenga LHJ, Biermann K; ProBar study group and Palga Group.

Am J Surg Pathol. 2018 Jul;42(7):918-926. doi: 10.1097/PAS.0000000000001066.

PMID:
29697438
6.

Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining.

van der Wel MJ, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus GJA, Visser M, Ten Kate FJ, Biermann K, Brosens LAA, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten GI, Moll FCP, Ooms AHAG, van der Valk H, Tijssen JG, Bergman JJ, Meijer SL.

Histopathology. 2018 May;72(6):1015-1023. doi: 10.1111/his.13462. Epub 2018 Feb 28.

PMID:
29314176
7.

Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma.

Ten Kate FJC, Suzuki L, Dorssers LCJ, Dinjens WNM, Jones DTW, Nieboer D, Doukas M, Van Lanschot JJB, Wijnhoven BPL, Looijenga LHJ, Biermann K.

Oncotarget. 2017 Oct 24;8(61):104123-104135. doi: 10.18632/oncotarget.22021. eCollection 2017 Nov 28.

8.

Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial.

Noordman BJ, Verdam MGE, Lagarde SM, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch OR, Ten Kate FJW, Creemers GM, Punt CJA, Plukker JTM, Verheul HMW, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A, Sprangers MAG, van Lanschot JJB.

J Clin Oncol. 2018 Jan 20;36(3):268-275. doi: 10.1200/JCO.2017.73.7718. Epub 2017 Nov 21.

PMID:
29161204
9.

Digital microscopy as valid alternative to conventional microscopy for histological evaluation of Barrett's esophagus biopsies.

van der Wel MJ, Duits LC, Seldenrijk CA, Offerhaus GJ, Visser M, Ten Kate FJ, de Boer OJ, Tijssen JG, Bergman JJ, Meijer SL.

Dis Esophagus. 2017 Nov 1;30(11):1-7. doi: 10.1093/dote/dox078.

PMID:
28881901
10.

Progress towards non-invasive diagnosis and follow-up of celiac disease in children; a prospective multicentre study to the usefulness of plasma I-FABP.

Adriaanse MPM, Mubarak A, Riedl RG, Ten Kate FJW, Damoiseaux JGMC, Buurman WA, Houwen RHJ, Vreugdenhil ACE; Celiac Disease Study Group.

Sci Rep. 2017 Aug 17;7(1):8671. doi: 10.1038/s41598-017-07242-4.

11.

Polypoid arteriovenous malformation of the ureter mimicking a fibroepithelial polyp, a case report.

Ten Donkelaar CS, Houwert AC, Ten Kate FJW, Lock MTWT.

BMC Urol. 2017 Jul 10;17(1):55. doi: 10.1186/s12894-017-0237-z.

12.

Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma.

Ten Kate FJC, van Olphen SH, Bruno MJ, Wijnhoven BPL, van Lanschot JJB, Looijenga LHJ, Fitzgerald RC, Biermann K.

Br J Surg. 2017 Sep;104(10):1327-1337. doi: 10.1002/bjs.10553. Epub 2017 Jul 10.

13.

Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B score.

Brouwer WP, van der Meer AJP, Boonstra A, Plompen EPC, Pas SD, de Knegt RJ, de Man RA, Ten Kate FJW, Janssen HLA, Hansen BE.

J Viral Hepat. 2017 Nov;24(11):1023-1031. doi: 10.1111/jvh.12727. Epub 2017 Jul 22.

PMID:
28544398
14.

Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer.

Shapiro J, Biermann K, van Klaveren D, Offerhaus GJ, Ten Kate FJ, Meijer SL, van Berge Henegouwen MI, Steyerberg EW, Wijnhoven BP, Lanschot JJ.

Ann Surg. 2017 Feb;265(2):356-362. doi: 10.1097/SLA.0000000000001630.

PMID:
28059964
15.

Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.

Duits LC, van der Wel MJ, Cotton CC, Phoa KN, Ten Kate FJW, Seldenrijk CA, Offerhaus GJA, Visser M, Meijer SL, Mallant-Hent RC, Krishnadath KK, Pouw RE, Tijssen JGP, Shaheen NJ, Bergman JJGHM.

Gastroenterology. 2017 Apr;152(5):993-1001.e1. doi: 10.1053/j.gastro.2016.12.008. Epub 2016 Dec 22.

PMID:
28012849
16.

Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control study.

van Olphen SH, Ten Kate FJ, Doukas M, Kastelein F, Steyerberg EW, Stoop HA, Spaander MC, Looijenga LH, Bruno MJ, Biermann K; ProBar-Study Group.

Medicine (Baltimore). 2016 Nov;95(47):e5402.

17.

Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.

Verbeek RE, Siersema PD, Vleggaar FP, Ten Kate FJ, Posthuma G, Souza RF, de Haan J, van Baal JW.

J Gastrointestin Liver Dis. 2016 Sep;25(3):273-82. doi: 10.15403/jgld.2014.1121.253.rc2.

18.

The Oncological Value of Omentectomy in Gastrectomy for Cancer.

Haverkamp L, Brenkman HJ, Ruurda JP, Ten Kate FJ, van Hillegersberg R.

J Gastrointest Surg. 2016 May;20(5):885-90. doi: 10.1007/s11605-016-3092-4. Epub 2016 Feb 19.

19.

Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.

Bus P, Kestens C, Ten Kate FJ, Peters W, Drenth JP, Roodhart JM, Siersema PD, van Baal JW.

J Gastroenterol. 2016 Jun;51(6):560-70. doi: 10.1007/s00535-015-1133-5. Epub 2015 Nov 19.

20.

National compliance to an evidence-based multidisciplinary guideline on pancreatic and periampullary carcinoma.

van Rijssen LB, van der Geest LG, Bollen TL, Bruno MJ, van der Gaast A, Veerbeek L, Ten Kate FJ, Busch OR.

Pancreatology. 2016 Jan-Feb;16(1):133-7. doi: 10.1016/j.pan.2015.10.002. Epub 2015 Oct 26.

PMID:
26560441
21.

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch ORC, Ten Kate FJW, Creemers GM, Punt CJA, Plukker JTM, Verheul HMW, Bilgen EJS, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A; CROSS study group.

Lancet Oncol. 2015 Sep;16(9):1090-1098. doi: 10.1016/S1470-2045(15)00040-6. Epub 2015 Aug 5.

PMID:
26254683
22.

Immunohistochemical CD3 staining detects additional patients with celiac disease.

Mubarak A, Wolters VM, Houwen RH, ten Kate FJ.

World J Gastroenterol. 2015 Jun 28;21(24):7553-7. doi: 10.3748/wjg.v21.i24.7553.

23.

Cryospray ablation using pressurized CO2 for ablation of Barrett's esophagus with early neoplasia: early termination of a prospective series.

Verbeek RE, Vleggaar FP, Ten Kate FJ, van Baal JW, Siersema PD.

Endosc Int Open. 2015 Apr;3(2):E107-12. doi: 10.1055/s-0034-1390759. Epub 2015 Feb 27.

24.

Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study.

Timmer MR, Martinez P, Lau CT, Westra WM, Calpe S, Rygiel AM, Rosmolen WD, Meijer SL, Ten Kate FJ, Dijkgraaf MG, Mallant-Hent RC, Naber AH, van Oijen AH, Baak LC, Scholten P, Böhmer CJ, Fockens P, Maley CC, Graham TA, Bergman JJ, Krishnadath KK.

Gut. 2016 Oct;65(10):1602-10. doi: 10.1136/gutjnl-2015-309642. Epub 2015 Jun 23.

25.

Oncologic Long-Term Results of Robot-Assisted Minimally Invasive Thoraco-Laparoscopic Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer.

van der Sluis PC, Ruurda JP, Verhage RJ, van der Horst S, Haverkamp L, Siersema PD, Borel Rinkes IH, Ten Kate FJ, van Hillegersberg R.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1350-6. doi: 10.1245/s10434-015-4544-x. Epub 2015 May 29.

26.

The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.

Prins MJ, Ruurda JP, Lolkema MP, Sitarz R, Ten Kate FJ, van Hillegersberg R.

J Clin Pathol. 2015 Jul;68(7):529-35. doi: 10.1136/jclinpath-2015-202962. Epub 2015 Apr 8.

PMID:
25855799
27.

Liver fibrosis during the development of biliary atresia: Proof of principle in the murine model.

Keyzer-Dekker CM, Lind RC, Kuebler JF, Offerhaus GJ, Ten Kate FJ, Morsink FH, Verkade HJ, Petersen C, Hulscher JB.

J Pediatr Surg. 2015 Aug;50(8):1304-9. doi: 10.1016/j.jpedsurg.2014.12.027. Epub 2015 Jan 23.

PMID:
25783404
28.

Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).

Phoa KN, Pouw RE, Bisschops R, Pech O, Ragunath K, Weusten BL, Schumacher B, Rembacken B, Meining A, Messmann H, Schoon EJ, Gossner L, Mannath J, Seldenrijk CA, Visser M, Lerut T, Seewald S, ten Kate FJ, Ell C, Neuhaus H, Bergman JJ.

Gut. 2016 Apr;65(4):555-62. doi: 10.1136/gutjnl-2015-309298. Epub 2015 Mar 2.

PMID:
25731874
29.

Whole slide images for primary diagnostics of urinary system pathology: a feasibility study.

Al-Janabi S, Huisman A, Jonges GN, Ten Kate FJ, Goldschmeding R, van Diest PJ.

J Renal Inj Prev. 2014 Dec 1;3(4):91-6. doi: 10.12861/jrip.2014.26. eCollection 2014.

30.

Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer.

Shapiro J, van Hagen P, Lingsma HF, Wijnhoven BP, Biermann K, ten Kate FJ, Steyerberg EW, van der Gaast A, van Lanschot JJ; CROSS Study Group.

Ann Surg. 2014 Nov;260(5):807-13; discussion 813-4. doi: 10.1097/SLA.0000000000000966.

PMID:
25379852
31.

Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival.

Koen Talsma A, Shapiro J, Looman CW, van Hagen P, Steyerberg EW, van der Gaast A, van Berge Henegouwen MI, Wijnhoven BP, van Lanschot JJ; CROSS Study Group, Hulshof MC, van Laarhoven HW, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW.

Ann Surg. 2014 Nov;260(5):786-92; discussion 792-3. doi: 10.1097/SLA.0000000000000965.

PMID:
25379850
32.

Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: a prospective follow-up study.

Davelaar AL, Calpe S, Lau L, Timmer MR, Visser M, Ten Kate FJ, Parikh KB, Meijer SL, Bergman JJ, Fockens P, Krishnadath KK.

Genes Chromosomes Cancer. 2015 Feb;54(2):82-90. doi: 10.1002/gcc.22220. Epub 2014 Oct 4.

PMID:
25284618
33.

The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients.

Brouwer WP, van der Meer AJ, Boonstra A, Pas SD, de Knegt RJ, de Man RA, Hansen BE, ten Kate FJ, Janssen HL.

Liver Int. 2015 Feb;35(2):438-47. doi: 10.1111/liv.12695. Epub 2014 Oct 24.

PMID:
25284145
34.

CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses.

Spaan M, Kreefft K, de Graav GN, Brouwer WP, de Knegt RJ, ten Kate FJ, Baan CC, Vanwolleghem T, Janssen HL, Boonstra A.

J Hepatol. 2015 Feb;62(2):303-10. doi: 10.1016/j.jhep.2014.09.024. Epub 2014 Oct 2.

PMID:
25281860
35.

Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel.

Duits LC, Phoa KN, Curvers WL, Ten Kate FJ, Meijer GA, Seldenrijk CA, Offerhaus GJ, Visser M, Meijer SL, Krishnadath KK, Tijssen JG, Mallant-Hent RC, Bergman JJ.

Gut. 2015 May;64(5):700-6. doi: 10.1136/gutjnl-2014-307278. Epub 2014 Jul 17.

PMID:
25034523
36.

Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study.

Verbeek RE, Leenders M, Ten Kate FJ, van Hillegersberg R, Vleggaar FP, van Baal JW, van Oijen MG, Siersema PD.

Am J Gastroenterol. 2014 Aug;109(8):1215-22. doi: 10.1038/ajg.2014.156. Epub 2014 Jul 1.

PMID:
24980881
37.

Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.

Wiggers JK, Ruys AT, Groot Koerkamp B, Beuers U, ten Kate FJ, van Gulik TM.

J Gastroenterol Hepatol. 2014 Aug;29(8):1582-94. doi: 10.1111/jgh.12620. Review.

PMID:
24787096
38.

Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.

Phoa KN, van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, Ragunath K, Fullarton G, Di Pietro M, Ravi N, Visser M, Offerhaus GJ, Seldenrijk CA, Meijer SL, ten Kate FJ, Tijssen JG, Bergman JJ.

JAMA. 2014 Mar 26;311(12):1209-17. doi: 10.1001/jama.2014.2511.

PMID:
24668102
39.

The role of routine preoperative EUS when performed after contrast enhanced CT in the diagnostic work-up in patients suspected of pancreatic or periampullary cancer.

Cieslak KP, van Santvoort HC, Vleggaar FP, van Leeuwen MS, ten Kate FJ, Besselink MG, Molenaar IQ.

Pancreatology. 2014 Mar-Apr;14(2):125-30. doi: 10.1016/j.pan.2014.01.001. Epub 2014 Jan 10.

PMID:
24650967
40.

Familial clustering of Barrett's esophagus and esophageal adenocarcinoma in a European cohort.

Verbeek RE, Spittuler LF, Peute A, van Oijen MG, Ten Kate FJ, Vermeijden JR, Oberndorff A, van Baal JW, Siersema PD.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1656-63.e1. doi: 10.1016/j.cgh.2014.01.028. Epub 2014 Jan 28.

PMID:
24480679
41.

Narrow band imaging does not reliably predict residual intestinal metaplasia after radiofrequency ablation at the neo-squamo columnar junction.

Alvarez Herrero L, Curvers WL, Bisschops R, Kara MA, Schoon EJ, ten Kate FJ, Visser M, Weusten BL, Bergman JJ.

Endoscopy. 2014 Feb;46(2):98-104. doi: 10.1055/s-0033-1344986. Epub 2014 Jan 29.

PMID:
24477364
42.

Consistency of a high-grade dysplasia diagnosis in Barrett's oesophagus: a Dutch nationwide cohort study.

Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, van Baal JW, Siersema PD.

Dig Liver Dis. 2014 Apr;46(4):318-22. doi: 10.1016/j.dld.2013.11.010. Epub 2013 Dec 30.

PMID:
24388501
43.

Pseudo-buried Barrett's post radiofrequency ablation for Barrett's esophagus, with or without prior endoscopic resection.

Pouw RE, Visser M, Odze RD, Sondermeijer CM, ten Kate FJ, Weusten BL, Bergman JJ.

Endoscopy. 2014 Feb;46(2):105-9. doi: 10.1055/s-0033-1358883. Epub 2013 Nov 27.

PMID:
24285123
44.

Children with celiac disease and high tTGA are genetically and phenotypically different.

Mubarak A, Spierings E, Wolters VM, Otten HG, ten Kate FJ, Houwen RH.

World J Gastroenterol. 2013 Nov 7;19(41):7114-20. doi: 10.3748/wjg.v19.i41.7114.

45.

Exogenous pigment in Peyer patches of children suspected of having IBD.

Hummel TZ, Kindermann A, Stokkers PC, Benninga MA, ten Kate FJ.

J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):477-80. doi: 10.1097/MPG.0000000000000221.

PMID:
24164906
46.

Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa.

Shapiro J, ten Kate FJ, van Hagen P, Biermann K, Wijnhoven BP, van Lanschot JJ.

Ann Surg. 2013 Nov;258(5):678-88; discussion 688-9. doi: 10.1097/SLA.0b013e3182a6191d.

PMID:
24096766
47.

Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.

Ruys AT, Groot Koerkamp B, Wiggers JK, Klümpen HJ, ten Kate FJ, van Gulik TM.

Ann Surg Oncol. 2014 Feb;21(2):487-500. doi: 10.1245/s10434-013-3286-x. Epub 2013 Oct 1. Review.

PMID:
24081803
48.

Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray study.

Prins MJ, Ruurda JP, van Diest PJ, van Hillegersberg R, ten Kate FJ.

J Clin Pathol. 2014 Jan;67(1):26-32. doi: 10.1136/jclinpath-2013-201570. Epub 2013 Sep 16.

PMID:
24043715
49.

Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression.

Verbeek RE, Siersema PD, Ten Kate FJ, Fluiter K, Souza RF, Vleggaar FP, Bus P, van Baal JW.

J Gastroenterol. 2014 Jul;49(7):1121-34. doi: 10.1007/s00535-013-0862-6. Epub 2013 Aug 17.

PMID:
23955118
50.

Severe cholestasis due to disseminated histoplasmosis under adalimumab-containing immunosuppressive therapy.

van Welzen BJ, van Erpecum KJ, Haas PJ, ten Kate FJ, Mudrikova T.

Clin Res Hepatol Gastroenterol. 2013 Sep;37(4):e105-7. doi: 10.1016/j.clinre.2013.03.008. Epub 2013 May 8. No abstract available.

PMID:
23663920

Supplemental Content

Loading ...
Support Center